Spinal Device Market

Key data points: Market size in 2027 = $16.9 billion and 2035 = $25.6 billion, growth forecast = 3.4% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in spinal device market to 2035 by type (spinal fusion and non-fusion products), application (open surgery and minimally invasive surgery), and region (North America, Europe, Asia Pacific, and the Rest of the World) Spinal Device Market The future of the global spinal device market looks promising with opportunities in the open surgery and minimally invasive surgery markets. The global spinal device market is expected to reach an estimated $25.6 billion by 2035 from $16.9 billion in 2027 with a CAGR of 3.4% from 2027 to 2035. The major drivers for this market are the increasing incidence of spinal disorders cases, the rising demand for minimally invasive spine surgery, and the growing adoption of advanced spinal technologies. • Lucintel forecasts that, within the type category, non-fusion products is expected to witness higher growth over the forecast period due to non-fusion products help preserve spinal mobility. • Within the application category, minimally invasive surgery is expected to witness higher growth over the forecast period due to recover more quickly from less invasive procedures. • In terms of regions, APAC is expected to witness the highest growth over the forecast period due to surgical intervention is sought more frequently as the prevalence of spinal disorders increases. Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below. Emerging Trends in Spinal Device Market From 2025 to 2027, changes in the spinal device market will be dominated by innovations in evidence-based spine implants, ambulatory care and supply chain and workflow optimizations. Luminar instrumentation and increasing patient demand will offset revenue loss from value-based purchasing. In the coming years, Lucintel expects most industry advancements will be in the field of navigation and manufacturing. • Ambulatory Care: The use of navigation systems and robotic systems to facilitate outpatient spinal surgery will gain in adoption and help reduce variation in implant placement. In the coming years, we expect the focus of innovations in the field will be on the development of integrated and compact systems for spinal surgery that support and enable outpatient care. • Patient-specific Implants: Innovations in imaging will permit the design of spinal implants with a varying degree of patient-specific customization. Initial FDA clearances have been granted to a few 3D printed devices. • Digital Surgery: Integrated imaging, navigation and other systems that facilitate and aid digital surgery and planning will gain in use. However, regional variation in reimbursement will slow the pace of adoption. • Integration of Biologics: There is increasing demand for implants combined with bone graft substitutes for fusions to address non-union. The U.S. performed over 1.6 million spinal procedures in 2023. This offers a significant market potential. Distinguishing products will require evidence. Barriers to entry will be lower for products structured to rely on reimbursement. • Supply Chain: Changes in supply and production, as well as the incorporation of automated systems and 3D printing, will enable more flexible and localized production. This, combined with improved supply chain information and planning systems, will allow medical device manufacturers to meet customer requirements more effectively and efficiently. The medical device market will require products that enhance outcomes, improve effectiveness, and increase the speed of recovery. The focus will be on products that integrate various supply and production systems to create greater flexibility. Systems that facilitate the integration of new technology to shorten and improve the quality of life for patients will gain market share. Recent Developments in the Spinal Device Market The market for spinal devices is poised for growth between 2025 and 2027, particularly as hospitals drive adoption for devices that facilitate outpatient procedures and reduce hospital length of stay. According to Lucintel, the competitive environment will be driven by investment in enabling technologies, biologics, surgical navigation, and surgical planning and case management. Larger spinal implant companies have pursued an acquisition and product launch strategy. Other strategies have been constrained by the uncertainty in the spinal implant product reimbursement environment. • Outpatient Surgery: Stryker’s focus on the outpatient surgery market increased in 2025, and the company allocated resources to expand that capacity across its medical device business. The market for spinal implants and instruments that support outpatient procedures will grow along with this capacity. • Surgery Navigation: Image guidance and surgical navigation will play a larger role in spinal procedures. In 2025, the Investor Communications of Medtronic indicated that the company’s integrated surgical solutions would allow spinal procedures to be performed using Stealth Station technology and the Hugo platform. • Interbody Fusion: The competitive environment for interbody devices will be focused on inventory reduction and improvement of radiographic quality. In 2025, Orthofix released its WaveForm L device, and other suppliers will be compelled to improve the osseointegration of their products. • Biologics: The spinal biologics market will be competitive based on the rate of fusion and other clinical endpoints. 2025 saw several suppliers gain FDA clearance for their spinal biologics. • Strategic Consolidation: Since completing its $3.1 billion acquisition of NuVasive in May 2023, Globus Medical has begun its integration process. During the next 3 to 5 years, Globus will expand the products and services it offers, as well as the geographical reach of its sales distribution. This will increase competitive advantages, particularly as hospitals work to partner with fewer, larger suppliers. The growth of the medical device industry will come from advances in technology that improve the accuracy of medical devices and facilitate a faster recovery for patients. Also, the ongoing shift of traditional in-patient procedures to out-patient procedures will create opportunities for medical device manufacturers. Manufacturers that offer integrated systems and medical devices with the best clinical evidence will probably experience the greatest growth. Strategic Growth Opportunities in the Spinal Device Market The changes in reimbursement and the shift toward outpatient surgery will transform the market and impact purchasing decisions by OEMs around 2024-26. OEMs should provide evidence of cost and clinical outcomes. Lucintel expects that the market will create opportunities for companies to offer a range of products and services based on the company’s understanding of the unmet clinical needs. • Motion-preserving Implants: Technologies exist that enable spine surgeons to perform total joint replacement-like procedures to replace spinal discs and/or nuclei. Spinal fusions create major shifts in spinal alignment and may increase the likelihood of adjacent-segment disease. Further, spinal fusions do not always result in a improved patient outcomes. As the number of spinal fusions continues to rise (the FDA reported that in 2020, there were over 100,000 spinal fusion surgeries performed in the U.S.), there may be increased interest by the surgery community in disc and nucleus replacement. • Ambulatory Care: Advances in implants and instrumentation may allow procedures that were once only performed in a hospital to be performed in an outpatient setting. The Centers for Medicare and Medicaid Services (CMS) has created a list of 11 spine procedures that may be performed in an outpatient setting. Furthermore, the 2018 Outpatient Prospective Payment System (OPPS) rule allowed CMS to create Hospital Outpatient Payment (HOP) pathways for 65 different procedures, a list that may incentivize medical device companies to focus on outpatient spine procedures. • Regenerative Products and Biologics: The spinal fusion market is ripe for the use of allografts, biologics, and other products that help decrease the need for autologous grafts. Since 2010, the FDA has approved 20 different product categories of bone allografts. Clinical studies have supported the use of allografts and other biologics for spinal fusion in the cervical and lumbar regions. • Distribution: Emerging markets: e.g. Latin America and Southeast Asia, represent untapped potential. Specialist knowledge and capacity continue to improve. As of April 2025, over 550 million beneficiaries in India’s Ayushman Bharat scheme represented a significant opportunity for service providers. • Connected Post-Operative Care: Software and other products related to post-operative care and follow-up can generate revenue for years after a medical device is sold. Telehealth services, of which Medicare estimated over 5 million in May 2025, offer similar opportunities. Companies should consider how data and software products can strengthen their contracts with health facilities. Evidence regarding the safety and effectiveness of devices will continue to determine pricing. Devices, when combined with other products, such as implants and/or biologics, used in conjunction with outpatient procedures and other products that provide data or software to support and measure the effect of the device, can help companies achieve greater market share. There are particularly good opportunities in procedures related to the migration of patient care from one location to another. Continuing regulation of the medical devices industry will help commercial and market opportunities, especially if companies make false or unsubstantiated claims, or maintain inadequate registries. Spinal Device Market Drivers and Challenges The global spinal device market is primarily influenced by advances in technology, procurement of new age devices by healthcare systems, and improvements in reimbursement policies. Manufacturers strive to create differentiated products and solutions. Increasing prevalence of spinal disorders and rising awareness regarding advanced intervention options have created an acceptability barrier for solutions that are first generation, invasive, and do not address the primary problems. Access, cost and the balance between benefit and risk (especially in the case of new age devices) play an important role in limiting the market. According to Lucintel, the panoply of solutions that address this unmet need should incorporate novel, and advanced materials, and integrate sophisticated, and complex processes. Further, solutions should be designed to reduce disparities in healthcare, whilst providing long term clinical benefits. The factors responsible for driving this market include : • Minimally Invasive Technology: Improvements in navigational technology, robotics, endoscopic instrumentation, and biocompatible implant materials have allowed for less invasive procedures, including approaches to the spine. Robotic systems, especially, have evolved to the point where many surgeons believe that the automated element of these systems will increase the safety and efficacy of spinal procedures. The use of three-dimensional models in surgical planning has gained widespread acceptance and provides the surgeon with the ability to place spinal hardware in the precise location. The focus on minimally invasive procedures will continue to create new opportunities for the spinal technology industry. • Product Innovation: The emphasis on improving spinal technologies has fostered the advancement of other adjacent technologies such as fixation devices, biologics, and motion-sparing devices. Additive manufacturing has allowed for the creation of spinal implants with characteristics that promote osseointegration. Currently, these characteristics are primarily limited to the structure of the implant. Within the next several years, the same principles will be extended to other technologies. • Regulatory and Clinical Support: The guidance provided by the U.S. Food and Drug Administration has helped streamline the pathway for the development of spinal technologies. Concurrently, the FDA has placed more stringent requirements for premarket approval of spinal technologies. These changes will be most beneficial to spinal technologies with a significant body of clinical evidence and will facilitate the introduction of novel spinal technologies to the market. • Manufacturing Improvements: Additive manufacturing has allowed for shorter product development cycles and a greater ability to manufacture customized products. One study found that various manufacturing processes sped up the development of some implant designs from months to weeks. Improvements in manufacturing processes and product development cycles allow for the creation of more personalized products and marginal inventory. These improvements, coupled with reductions in product costs, will enable medical device companies to meet the needs of value-based purchasing and create a positive economic impact on the healthcare system. • Increased Prevalence of Spinal Disorders: The increased prevalence of spinal disorders and conditions (i.e. fractures, stenosis, disc degeneration, and deformities, etc.) has caused an increased demand for medical devices to diagnose, and/or treat spinal conditions. The challenges facing this market include: • High Costs of Treatment and Medical Devices: High costs of spinal implants and procedures drive up the overall costs of medical care. Other costs associated with spinal procedures including surgery, hospital stay, imaging, and rehabilitation are not always considered when determining the overall cost of care. In 2025, the cost of a single spinal surgery in the U.S. could exceed $20,000. Competing against high-cost implants will require other medical devices and equipment to lower the cost of total medical care. The implant or device will also need to reduce the length of hospital stays and decrease the number of required surgeries to be cost-effective. • Changes in Reimbursement and Regulation: Changes in reimbursement policies will affect the cost of new implant and medical devices. The cost of new medical devices and implants will also be determined by regulations related to the safety and efficacy of new products. The overall cost of new implant and medical devices used to perform spinal surgery will also be determined by the amount a hospital is able to spend due to participation in bundled payment programs. • Product Liability and Clinical Risks: Infections, migration of implants, non-unions, adjacent segment disease, neurological injuries, and further revisions continue to be risks of spinal implant surgeries. Non-unions of spinal fusions have been reported at 5%-15%, and are affected by the risks of the patient and the type of procedure. These risks will impact what spinal implant products are purchased, who performs the procedures, and liability exposure in the near future. Companies will need to enhance their design, post-market surveillance, and improve their evidence in order to retain their clientele. Improvements in spinal implant technologies and less invasive techniques to treat spinal conditions have increased and improved the spinal device market. There are opportunities for further innovation. Advances in manufacturing and biocompatible materials have enabled the development of more sophisticated and safer spinal implantable devices. Costs and reimbursement may limit the distribution of spinal implantable devices. There is a disconnect between the leading innovations in the area of spinal implantable devices and the populations who would greatly benefit from them. In the next several years, the most successful companies in the spinal implantable device market will merge superior technologies, manufacturing and design at a price that provides the best value while improving clinical outcomes and safety. List of Spinal Device Market Companies Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies spinal device market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the spinal device market companies profiled in this report include- • Medtronic • J & J • Globus Medical • Stryker • WEGO Spinal Device Market by Segment The study includes a forecast for the global spinal device market by type, application, and region. Spinal Device Market by Type [Value ($B) from 2019 to 2035]: • Spinal Fusion • Non-fusion Products Spinal Device Market by Application [Value ($B) from 2019 to 2035]: • Open Surgery • Minimally Invasive Surgery Spinal Device Market by Region [Value ($B) from 2019 to 2035]: • North America • Europe • Asia Pacific • The Rest of the World Country Wise Outlook for the Spinal Device Market he spinal device market is focusing more on strategic initiatives and less on larger product launches. In the 2025-2027 time period, companies will concentrate more on the expansion of regional manufacturing and integration of surgical navigation and robotic systems with spinal devices. According to Lucintel’s most recent market report, this would create an intensifying level of competition within the healthcare market. • United States: The FDA approval process and allocation of capital continue to facilitate the growth of spinal procedures enabled by surgical software and related systems. In February 2025, Medtronic launched its AiBLE digital surgery system in the United States. As cited in a January 2025 report by Pyramid, spinal implant systems integrated with surgical software and services would be well-positioned to capture potentially high-value, multi-year contracts with hospitals, given the hospitals’ focus on improving surgical outcomes and patient safety. • China: In January 2025, the Chinese National Healthcare Security Administration (NHSA) extended its centralized purchasing program to include certain high-value spinal implants, deepening the focus on price and procurement in China’s spinal implant market. Continued focus on price would likely encourage further investment in local manufacturing and design by suppliers in China. • Germany: Investments in local manufacturing facilities and strategic alliances enable German firms to build positioning and robotic systems for the medical device market. In March 2025, Brainlab deployed its image-guided surgery platform in additional hospitals to perform cranial and spinal surgeries. Germany’s advanced hospital system provides an excellent market opportunity to adoption of integrated surgical planning systems and procedures. • India: Both public and private medical device manufacturing increased in 2025. In June, the Indian government announced an extension of its pledged-manufacturing scheme, inviting investments to set up facilities for production of advanced surgical equipment and implants. This benefits the market because spinal implants and devices can be designed, manufactured, and validated locally. • Japan: Advanced spinal devices gained reimbursement, consequently allowing Navigation-based spinal surgeries and other advanced spinal implants to be funded. In June, Japan’s Ministry of Health, Labor and Welfare, retained reimbursement for spinal implants and devices. Japan provides an excellent market opportunity for companies designing spinal implants and devices. Features of the Global Spinal Device Market Market Size Estimates: spinal device market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions. Segmentation Analysis: spinal device market size by type, application, and region in terms of value ($B). Regional Analysis: spinal device market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the spinal device market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the spinal device market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model. If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more. This report answers following 11 key questions: Q.1. What are some of the most promising, high-growth opportunities for the spinal device market by type (spinal fusion and non-fusion products), application (open surgery and minimally invasive surgery), and region (North America, Europe, Asia Pacific, and the Rest of the World)? Q.2. Which segments will grow at a faster pace and why? Q.3. Which region will grow at a faster pace and why? Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market? Q.5. What are the business risks and competitive threats in this market? Q.6. What are the emerging trends in this market and the reasons behind them? Q.7. What are some of the changing demands of customers in the market? Q.8. What are the new developments in the market? Which companies are leading these developments? Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth? Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution? Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?